Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis

Bibliography

• Dong S, Inoue A, Zhu Y, et al. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF 7 cells by the treatment withan extract of Glycyrrhiza glabra root. Food Chem Toxicol 2007;45:2470-8
   PubMed Web of Science ®Google Scholar
• Kim SC, Park SJ, Lee JR, et al. Cytoprotective activity of glycyrrhizae radix extract against arsenite induced cytotoxicity. eCAM 2008;2:165-71
   Google Scholar
• Satomi Y, Nishino H, Shibata S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res 2005;25:4043-7
   PubMed Web of Science ®Google Scholar
• Chadalapaka G, Jutooru I, McAlees A, et al. Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives. Bioorg Med Chem Lett 2008;18:2633-9
   PubMed Web of Science ®Google Scholar
• Hibasami H, Iwase H, Yoshioka K, et al. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int J Mol Med 2006;17:215-19
   PubMed Web of Science ®Google Scholar
• Abe H, Ohya N, Yamamoto KF, et al. Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells. Eur J Cancer Clin Oncol 1987;23:1549-55
   PubMedGoogle Scholar
• Sharma G, Kar S, Palit S, et al. 18beta-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells. J Cell Physiol 2012;227:1923-31
   PubMedGoogle Scholar
• Shetty AV, Thirugnanam S, Dakshinamoorthy G, et al. 18alpha-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes. Int J Oncol 2011;39:635-40
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Noshita T, Yu T, et al. Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity. Eur J Med Chem 2010;45:2943-8
   PubMed Web of Science ®Google Scholar
• Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003;22:6524-36
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002;3:207-14
   PubMed Web of Science ®Google Scholar
• Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer metastasis reviews 2008;27:679-90
   PubMedGoogle Scholar
• Mohammad MA, Zeeneldin AA, Abd Elmageed ZY, et al. Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue. Mol Cell Biochem 2012;366:269-75
   PubMedGoogle Scholar
• Jones JL, Glynn P, Walker RA. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 1999;189:161-8
   PubMed Web of Science ®Google Scholar
• Kim TD, Song KS, Li G, et al. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 2006;6:211
   PubMed Web of Science ®Google Scholar
• Matsuyama Y, Takao S, Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol 2002;80:105-10
   PubMed Web of Science ®Google Scholar
• Bodey B, Bodey BJr, et al. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung. In Vivo 2001;15:175-80
   PubMed Web of Science ®Google Scholar
• Xu L, Chen S, Bergan RC. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 2006;25:2987-98
   Google Scholar
• Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004;25:1375-82
   PubMed Web of Science ®Google Scholar
• Shin I, Kim S, Song H, et al. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 2005;280:14675-83
   PubMed Web of Science ®Google Scholar
• Mao L, Yuan L, Slakey LM, et al. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res 2010;12:R107
   PubMed Web of Science ®Google Scholar
• Lungu G, Covaleda L, Mendes O, et al. FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1. Mol Carcinog 2008;47:424-35
   PubMedGoogle Scholar
• Huang S, Jiang Y, Li Z, et al. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 1997;6:739-49
   PubMed Web of Science ®Google Scholar
• Chen H, Zhu G, Li Y, et al. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res 2009;69:9228-35
   PubMedGoogle Scholar
• Huang S, Stupack D, Mathias P, et al. Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes. Proc Natl Acad Sci USA 1997;94:8156-61
   PubMed Web of Science ®Google Scholar
• Zhou QM, Wang XF, Liu XJ, et al. Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects. Eur J Cancer 2011;47:2240-7
   PubMed Web of Science ®Google Scholar
• Whyte J, Bergin O, Bianchi A, et al. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res 2009;11:209
   PubMed Web of Science ®Google Scholar
• Ferreiro I, Barragan M, Gubern A, et al. The p38 SAPK is recruited to chromatin via its interaction with transcription factors. J Biol Chem 2010;285:31819-28
   PubMedGoogle Scholar
• Tanos T, Marinissen MJ, Leskow FC, et al. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 2005;280:18842-52
   PubMed Web of Science ®Google Scholar
• Tsai PW, Shiah SG, Lin MT, et al. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 2003;278:5750-9
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics. 2008. CA Cancer J Clin 2008;58:71-96
   PubMed Web of Science ®Google Scholar
• Yadav DK, Kalani K, Singh AK, et al. Design, synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. Curr Med Chem 2014;9:1160-70
   Google Scholar
• Yadav DK, Kalani K, Khan F, et al. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549. Med Chem 2013;8:1073-84
   Google Scholar
• Huang S, New L, Pan Z, et al. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. J Biol Chem 2000;275:12266-72
   PubMed Web of Science ®Google Scholar
• Esteva FJ, Sahin AA, Smith TL, et al. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 2004;100:499-506
   PubMed Web of Science ®Google Scholar
• del Barco Barrantes I, Nebreda AR. Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans 2012;40:79-84
   PubMed Web of Science ®Google Scholar
• Behren A, Muhlen S, Acuna Sanhueza GA, et al. Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion. Oncogene 2010;29:1519-30
   PubMed Web of Science ®Google Scholar
• Gomes LR, Terra LF, Wailemann RA, et al. TGF-beta1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells. BMC Cancer 2012;12:26
   PubMedGoogle Scholar
• Hsieh MJ, Chen KS, Chiou HL, et al. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur J Cell Biol 2010;89:598-606
   PubMed Web of Science ®Google Scholar
• Kim IY, Yong HY, Kang KW, et al. Overexpression of ErbB2 induces invasion of MCF10A human breast epithelial cells via MMP-9. Cancer Lett 2009;275:227-33
   PubMedGoogle Scholar
• Noh EM, Youn HJ, Jung SH, et al. Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells. Int J Mol Med 2010;25:255-60
   PubMed Web of Science ®Google Scholar
• Byun HJ, Hong IK, Kim E, et al. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways. J Biol Chem 2006;281:34833-47
   PubMed Web of Science ®Google Scholar
• Jutooru I, Chadalapaka G, Chintharlapalli S, et al. Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative. Mol Carcinog 2009;48:692-702
   PubMedGoogle Scholar